Page 1 of Clinical Trials for recurrent adrenocortical carcinoma, 18 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
Gossypol Acetic Acid in Treating Patients With Recurrent, Metastatic, or Primary Adrenocortical Cancer That Cannot Be Removed By Surgery
Last Updated: April 7, 2011
Condition(s): Adrenocortical Carcinoma
2
Recruiting
Mitotane With or Without IMC-A12 in Treating Patients With Recurrent, Metastatic, or Primary Adrenocortical Cancer That Cannot Be Removed By Surgery
Last Updated: April 2, 2011
Condition(s): Adrenocortical Carcinoma
3
Completed
Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment
Last Updated: December 7, 2010
Condition(s): Adrenocortical Carcinoma; Brain and Central Nervous System Tumors; Childhood Germ Cell Tumor; Colorectal Cancer; Extragonadal Germ Cell Tumor; Head and Neck Cancer; Kidney Cancer; Liver Cancer; Neuroblastoma; Ovarian Cancer; Sarcoma
4
Completed
Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer
Last Updated: May 1, 2012
Condition(s): Adrenocortical Carcinoma; Breast Cancer; Colorectal Cancer; Gastrointestinal Cancer; Kidney Cancer; Liver Cancer; Melanoma (Skin); Ovarian Cancer; Pancreatic Cancer; Sarcoma
5
Completed
Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors
Last Updated: February 6, 2009
Condition(s): Adrenocortical Carcinoma; Brain and Central Nervous System Tumors; Head and Neck Cancer; Liver Cancer; Malignant Mesothelioma; Pheochromocytoma; Sarcoma
6
Completed
Combination Chemotherapy With Suramin Plus Doxorubicin in Treating Patients With Advanced Solid Tumors
Last Updated: August 2, 2011
Condition(s): Adrenocortical Carcinoma; Breast Cancer; Colorectal Cancer; Prostate Cancer; Unspecified Adult Solid Tumor, Protocol Specific
7
Recruiting
Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors
Last Updated: April 2, 2011
Condition(s): Adrenocortical Carcinoma; Kidney Cancer; Liver Cancer; Neuroblastoma; Retinoblastoma; Sarcoma
8
Recruiting
Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features
Last Updated: May 23, 2012
Condition(s): Adrenocortical Carcinoma; Gastrointestinal Carcinoid Tumor; Kidney Cancer; Neuroblastoma; Retinoblastoma; Sarcoma
9
Recruiting
Antineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland Cancer
Last Updated: June 9, 2009
Condition(s): Adrenocortical Carcinoma
10
Completed
Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain
Last Updated: February 19, 2012
Condition(s): Cancer
11
Completed
Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer
Last Updated: April 23, 2011
Condition(s): Cancer
12
Completed
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu
Last Updated: April 23, 2011
Condition(s): Cancer
13
Completed
MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma
Last Updated: March 14, 2012
Condition(s): Cancer
14
Recruiting
Sunitinib and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors That Have Not Responded to Chemotherapy
Last Updated: October 12, 2011
Condition(s): Cancer
15
Recruiting
Phase II Study of Axitinib (AG-013736) With Evaluation of the VEGF-Pathway in Metastatic, Recurrent or Primary Unresectable Adrenocortical Cancer
Last Updated: March 14, 2012
Condition(s): Adrenal Cortex Neoplasms
16
Completed
Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer
Last Updated: March 29, 2012
Condition(s): Peritoneal Neoplasms; Retroperitoneal Neoplasms; Gastrointestinal Neoplasms; Adenocarcinoma; Neuroblastoma; Ovarian Neoplasms; Sarcoma; Adrenocortical Carcinoma; Wilms Tumor; Rhabdomyosarcoma; Desmoplastic Small Round Cell Tumor
17
Terminated
A Study to Confirm Recurrent or Persistent Cushing's Syndrome in Patients With Signs or Symptoms of Hypercortisolemia
Last Updated: December 16, 2010
Condition(s): Cushing's Syndrome
18
Completed
A Study of the Safety and Effects of ADH-1 Given Intravenously as a Single Agent
Last Updated: August 3, 2007
Condition(s): Neoplasms

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=recurrent+adrenocortical+carcinoma

Page 1 of Clinical Trials for recurrent adrenocortical carcinoma, 18 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About